Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-123,012
| Closed | -$6.4M | – | 500 |
|
|
2025
Q2 | $6.4M | Buy |
123,012
+512
| +0.4% | +$29.1K | 0.02% | 508 |
|
|
2025
Q1 | $7.82M | Sell |
122,500
-9,391
| -7% | -$546K | 0.03% | 434 |
|
|
2024
Q4 | $6.31M | Buy |
131,891
+23,835
| +22% | +$1.22M | 0.02% | 481 |
|
|
2024
Q3 | $6.19M | Buy |
+108,056
| New | +$6.19M | 0.02% | 487 |
|
|
2024
Q2 | – | Sell |
-135,203
| Closed | -$5.5M | – | 1096 |
|
|
2024
Q1 | $5.5M | Buy |
135,203
+84,869
| +169% | +$3.18M | 0.02% | 536 |
|
|
2023
Q4 | $1.86M | Buy |
50,334
+24,834
| +97% | +$935K | 0.01% | 755 |
|
|
2023
Q3 | $974K | Buy |
25,500
+1,800
| +8% | +$73.7K | ﹤0.01% | 844 |
|
|
2023
Q2 | $855K | Sell |
23,700
-14,125
| -37% | -$482K | ﹤0.01% | 863 |
|
|
2023
Q1 | $1.44M | Buy |
37,825
+2,153
| +6% | +$101K | 0.01% | 813 |
|
|
2022
Q4 | $2.03M | Sell |
35,672
-21,000
| -37% | -$1.08M | 0.01% | 777 |
|
|
2022
Q3 | $2.24M | Buy |
+56,672
| New | +$2.5M | 0.01% | 738 |
|
|
2022
Q2 | – | Sell |
-5,200
| Closed | -$207K | – | 1151 |
|
|
2022
Q1 | $207K | Sell |
5,200
-86,500
| -94% | -$3.08M | ﹤0.01% | 1151 |
|
|
2021
Q4 | $3.69M | Sell |
91,700
-34,000
| -27% | -$1.27M | 0.01% | 739 |
|
|
2021
Q3 | $5.11M | Buy |
+125,700
| New | +$5.26M | 0.01% | 674 |
|
|
2021
Q1 | – | Sell |
-87,900
| Closed | -$3.75M | – | 1258 |
|
|
2020
Q4 | $3.75M | Buy |
+87,900
| New | +$3.16M | 0.01% | 750 |
|
|
2019
Q4 | – | Sell |
-25,000
| Closed | -$388K | – | 1227 |
|
|
2019
Q3 | $388K | Sell |
25,000
-411,419
| -94% | -$6.78M | ﹤0.01% | 1137 |
|
|
2019
Q2 | $7.5M | Buy |
436,419
+8,202
| +2% | +$132K | 0.03% | 538 |
|
|
2019
Q1 | $6.89M | Hold |
428,217
| – | – | 0.03% | 556 |
|
|
2018
Q4 | $6.26M | Hold |
428,217
| – | – | 0.03% | 545 |
|
|
2018
Q3 | $7.78M | Buy |
428,217
+37,108
| +9% | +$650K | 0.03% | 543 |
|
|
2018
Q2 | $6.6M | Buy |
+391,109
| New | +$7.39M | 0.03% | 576 |
|
|
2016
Q1 | – | Sell |
-44,060
| Closed | -$764K | – | 1357 |
|
|
2015
Q4 | $764K | Sell |
44,060
-32,540
| -42% | -$519K | ﹤0.01% | 957 |
|
|
2015
Q3 | $1.03M | Buy |
+76,600
| New | +$1.54M | ﹤0.01% | 906 |
|
|
2014
Q4 | – | Sell |
-117,208
| Closed | -$1.07M | – | 1432 |
|
|
2014
Q3 | $1.07M | Sell |
117,208
-753
| -0.6% | -$7.17K | ﹤0.01% | 891 |
|
|
2014
Q2 | $1.17M | Sell |
117,961
-4,745
| -4% | -$40.3K | ﹤0.01% | 894 |
|
|
2014
Q1 | $1.56M | Buy |
122,706
+6,389
| +5% | +$94.8K | 0.01% | 829 |
|
|
2013
Q4 | $1.74M | Buy |
116,317
+5,786
| +5% | +$74.4K | 0.01% | 800 |
|
|
2013
Q3 | $1.22M | Buy |
110,531
+22,255
| +25% | +$185K | 0.01% | 831 |
|
|
2013
Q2 | $701K | Buy |
+88,276
| New | +$562K | ﹤0.01% | 899 |
|
Other funds holding HALO
SCM
Axa's HALO Position: Q3 2025 in Review
Axa sold out of Halozyme (HALO) in Q3 2025, closing a stake of 123,012 shares — an estimated $6.4M sold.
Axa first reported a position in HALO in Q2 2013 and held it in 29 quarters. The position peaked at $7.82M in Q1 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.
- Axa reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
- Axa sold 123,012 Halozyme shares in Q3 2025, an estimated $6.4M.
- Axa first reported a position in Halozyme in Q2 2013 and held it in 29 quarters.
- Axa's Halozyme position peaked at $7.82M in Q1 2025.
- 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.